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Detection of antibodies to Anaplasma spp. using commercial competitive enzyme-linked
immunosorbent assay (ccELISA) is based on the recombinant major surface protein 5 fused
to maltose binding protein (MBP-MSP5) or glutathione S-transferase (GST-MSP5). To
avoid false positive reactions due to the presence of antibodies against E. coli MBP in
cattle, previous sera absorption is required. This study evaluated the replacement of MBP-
MSP5 or GST-MSP5 antigens by the truncate MSP5 (residues 28–210) of A. marginale
(tMSP5m), A. centrale (tMSP5c) and fusion protein MSP5 (tMSP5cm), expressed without
N-terminus transmembrane helix in the ccELISA test. Immunoreactivity was evaluated by
western blot using monoclonal antibodies against the tMSP5 and by in-house cELISA (hcE-
LISA) with purified tMSP5m, tMSP5c or tMSP5cm using sera from cattle infected with A.
marginale (n = 226) or vaccinated with A. centrale (n = 173) and uninfected cattle (n = 216).
Results of hcELISA were compared with those of ccELISA. Recombinant protein was
expressed highly soluble (> 95%) in E. coli without a molecular chaperone. Specificity of the
hcELISA-tMSP5m, -MSP5c or -tMSP5cm was identical to (99.5%) and greater than that in
ccELISA (96.3%). Sensitivity of hcELISA-tMSP5m and ccELISA was identical (95.5%), but
lower than that of hcELISA-tMSP5cm (96.2%) and -tMSP5c (97.2%). The analysis of vacci-
nated cattle by hcELISA-tMSP5c showed sensitivity of 99.4%. In summary, the generation
of fusion MSP5 A. marginale-A. centrale protein without transmembrane helix was a very
effective method to express the recombinant protein highly soluble in the bacterial cyto-
plasm and contributed to an increased test performance for detecting antibodies in cattle
naturally infected with A. marginale or vaccinated with A. centrale.
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Introduction
Bovine anaplasmosis is an infectious disease caused by the obligate intraerythrocytic bacte-
rium Anaplasma marginale [1] and is transmitted biologically to susceptible cattle by ticks or
mechanically by biting flies and fomites [2–4]. The disease is endemic in mainly tropical and
subtropical areas of the world. In Argentina, A. marginale is prevalent north of 33˚S; never-
theless, anaplasmosis outbreaks have been detected to the south of the endemic zone due to
the movement of carrier cattle to non-endemic areas [5,6]. Acute anaplasmosis affects mostly
adult bovines and is characterized by severe anemia with destruction of erythrocytes, abor-
tion, weight loss, reduced milk production and death. Cattle that recover from acute disease
remain carriers and serve as reservoirs for transmission to other animals [7]. Immunization
with live A. centrale, a species closely related to A. marginale, is used to prevent acute ana-
plasmosis in several countries worldwide, including Argentina. The immunogen causes only
mild clinical signs and does not prevent infection with A. marginale, but reduces disease
severity and prevents death [8]. The absence of anaplasmosis outbreaks in endemic areas is
achieved after a high proportion of calves become naturally infected with A. marginale or by
inoculation of young cattle with the A. centrale live vaccine, along with avoidance of the
entry of A. marginale-infected cattle to anaplasmosis-free zones of Argentina. Implementa-
tion of appropriate control measures requires highly sensitive and specific serological tests
that could provide mainly information on: i) precise identification of carriers, ii) epidemio-
logical status of anaplasmosis in calves from enzootic regions, and iii) the immune response
to A. centrale vaccine.
Several diagnostic assays have been developed and used in the field, including complement
fixation (CF) [9], card agglutination [9,10], indirect fluorescent antibody test (IFAT) [9], dot
ELISA [11], indirect enzyme-linked immunosorbent assay (ELISA) [12,13] and competitive
ELISA (cELISA) [14]. ELISAs are preferable to conventional tests because of their practicality,
objectivity, reliability, suitability for automation, fast turn-around time and often higher sensi-
tivity and specificity for detection of anaplasmosis carriers [4].
The commercial cELISA (ccELISA) recommended by the World Organization for Animal
Health (OIE) is based on the A. marginale recombinant major surface protein 5 (MSP5) fused
with E. coli maltose binding protein (MBP-MSP5) and on the monoclonal antibody (mAb)
ANAF16C1. For an endemic area of USA (A. centrale-free country), 96% sensitivity and 95%
specificity were reported using this test [15]. Although ccELISA is used for detecting antibod-
ies against A. centrale, the test has not been validated for this specific purpose.
MSP5 is a transmembrane protein of 210 residues (23kDa) present in all recognized Ana-
plasma species, and the MSP5 epitope defined by ANAF16C1 is broadly conserved, with cross-
reactivity described among A. marginale, A. centrale, A. ovis, A. phagocytophilum and Ehrlichia
sp. [16–18]. A strategy to enhance the expression of soluble protein is the use of molecular
chaperones. However, this approach could increase nonspecific reactions by interaction of
antibodies with chaperones or decrease specific reactions by hiding epitopes due to steric
impediments. The chaperone MBP enhances the expression of soluble MSP5, but also
increases the number of false positives due to antibodies against E. coli MBP, which are fre-
quently found in bovines. For this reason, an adsorption step of sera with MBP is required
before performing the analysis [14,19]. Chung et al. (2014) evaluated the replacement of MBP
with glutathione S-transferase (GST) for the expression of the soluble recombinant antigen in
a cELISA to detect antibodies against A. marginale. The authors reported that three types of
problems were solved: i) MBP binders; ii) nonspecific binders of unknown mechanism; and
iii) cELISA values close to the cutoff point. However, expression levels, purification or stability
of GST-MSP5 were not mentioned [19].
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In order to develop a highly specific and sensitive cELISA, not only for the detection of anti-
bodies in cattle infected with A. marginale, but also in bovines vaccinated with A. centrale, the
test was evaluated with a modified antigen. Two hypothesis were tested in this work: i) the
expression of a truncated MSP5 (tMSP5) variant without the amino-terminal hydrophobic
region in E. coli will allow for expression of soluble, recombinant protein avoiding the use of
molecular chaperones (MBP or GST); and ii) the inclusion of A. centrale MSP5 with the A. mar-
ginale antigen as a target in the ELISA will allow for the identification of vaccinated cattle with
high sensitivity without affecting the detection of animals naturally infected with A. marginale.
The aim of this study was to evaluate the use of the MSP5 truncated protein of A. marginale
(tMSP5m), A. centrale (tMSP5c) and A. centrale-A. marginale fusion (tMSP5cm) as antigen in
a cELISA. The sensitivity of the three versions of cELISA developed was analyzed according to
the cattle population (naturally infected or previously vaccinated calves).
Materials and methods
Cattle samples
Blood samples were aseptically collected with and without 5% citrate as anticoagulant from
three cattle groups. The first group included 255 cows born and raised in two Argentinean
farms, located in a highly endemic area of anaplasmosis. Both farms, “La Margarita” and “Don
Goyo” were located in Avia Terai, (26˚40’S—60˚46’W), and Villa Angela (27˚35’S—60˚43’W)
respectively, in the Chaco province. The second group included 173 calves vaccinated with a
single dose of 107 A. centrale parasitized erythrocytes, at least 4 months before of the beginning
of this study. The utilization of A. centrale vaccine has been approved by the National Agri
Food Health and Quality Service (N˚ 93159). The calves were from a herd historically free of
anaplasmosis, located in a temperate zone free of ticks (Rafaela, 31˚11’S—61˚30’W), owned by
INTA, at the Santa Fe province. The third group included 216 cows, also born and reared in
the above-mentioned anaplasmosis-free herd of INTA.
Blood and serum samples obtained from susceptible, healthy and splenectomised cattle
infected by intramuscular inoculation of 107 of A. marginale or A. centrale were used as posi-
tive controls. The cattle were isolated in boxes used ad hoc in the Agricultural Experimental
Station of the INTA of Rafaela. Food and water was provided ad libitum and general health sta-
tus of the animals was monitored daily. All protocols were approved by the Animal Care Com-
mittee of the Faculty of Veterinary Sciences, National University of Litoral (Protocol number
243/15). Samples were distributed in aliquots and kept at -20˚C until use.
DNA extraction
Genomic DNA (gDNA) was obtained from blood samples by the phenol/chloroform method.
Briefly, erythrocyte suspensions were lysed with erythrocyte lysis buffer (0.14 M NH4Cl, 0.17 M
Tris–HCl) at room temperature for 30 min and then pelleted. The hemoglobin was washed off
using distilled water by centrifugation at 14,000 × g for 15 min, and pellets were lysed in 400 μl
lysis buffer (0.05 M Tris–HCl pH 8.0, 0.1 M EDTA, 0.1 M NaCl, 2% SDS) with 160 μg of protein-
ase K (Invitrogen Corp., USA) at 58 ˚C for 1 h. gDNA was extracted with 1 volume of phenol/
chloroform/isoamyl alcohol, precipitated with ice-cold isopropyl alcohol and washed once with
75% ice-cold ethanol. Pellets were suspended in 50 μl distilled water and kept at -20 ˚C until use.
Status of infection
The status of anaplasmosis infection of sampled cattle was confirmed by nested-PCR (nPCR)
specifically validated for each species of Anaplasma [20]. Infection of calves vaccinated with A.
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centrale was also confirmed by direct microscopic examination of blood smears stained with
Giemsa.
In silico analysis of MSP5
Sequence alignment, presentation and determination of percent identity between A. marginale
and A. centrale MSP5 was performed using CLUSTAL W (1.83) (http://embnet.vital-it.ch/
software/ClustalW.html). TMPred algorithm (http://embnet.vital-it.ch/software/TMPRED_
form.html) was used to predict the transmembrane domains [21]. Solubility of full-length,
truncated MSP5 (residues 28–210) and fusion protein was calculated using a prediction model
based on E. coli overexpressed proteins (http://www.biotech.ou.edu/) [22].
Cloning of truncated msp5 gene from A. marginale and A. centrale
cDNA encoding residues 28-210 with a six-histidine tag at the C-terminus of the protein
MSP5 from A. marginale (tMSP5m) or MSP5 from A. centrale (tMSP5c) were amplified by
PCR using the primers MSP5-F 5’-catatgggtattttcagcaaaatc-3’ and MSP5-R
5’-ggatcctcagtgatggtgatggtgatggcggccttcaattttaaaagaattaagcat
gtgacc-3’. cDNA for tMSP5m and tMSP5c were cloned into pGEM–T Easy (Promega,
USA). Subsequently, a fragment was excised with Nde I and BamH I and subcloned into
pET9b (Novagen, USA) to yield ptMSP5m or ptMSP5c. The identity of the DNA construct
was confirmed by sequencing (Instituto de Biotecnologı́a, INTA CICVyA, Argentina).
Three PCR were used to generate the ptMSP5cm: PCR1 by amplification of tMSP5c using
ptMSP5c as template and primers 5´-tgcatgcaaggagatggcgcccaacagt-3´ (F-
pET9) and 5´-gctttcttatacagagaggtagaattaagcatg-3´ (R-1), PCR2 by amplifi-
cation of tMSP5m using pMSP5m and the primers 5´-ctctgtataagaaagcaggtggta
ttttcag-3´(F-2) and 5´-ttctccttcattacagaaacggct-3´ (R-pET9), and PCR3
using PCR1 and PCR2 products as template and primers F-pET9 and R-pET9. Sequence
underline of primers R-1 and F-2 are complementary and allow the fusion of the PCR1 and
PCR2 products.
Protein expression and purification
E. coli BL21 RIL (DE3)pLysS competent cells (Novagen, USA) transformed with ptMSP5m,
ptMSP5c or ptMSP5cm were cultured at 37˚C in 500 ml of Luria–Bertani medium supple-
mented with 50 μg/ml kanamycin and 34 μg/ml chloramphenicol to OD600 nm = 1. Protein
expression was induced with 1% lactose. After 3 h of induction at 37˚C, bacteria were har-
vested by centrifugation, suspended in 10 ml of lysis buffer (50 mM sodium phosphate, 300
mM NaCl, 10 mM imidazole, pH 8) containing 1/1000 protease inhibitor cocktail set III (Cal-
biochem, USA), and lysed by 2 passes through a cell disruptor at 20000 psi (Avestin Emulsiflex
B15, Canada). After centrifugation (12000 × g, 30 min, 4˚C), the soluble fraction was separated
and added to 2 ml of Ni-NTA agarose (Qiagen, Germany) previously equilibrated with lysis
buffer. After incubation at 4˚C for 1 h, the suspension was poured into a 1.5 cm × 5.0 cm col-
umn and washed with 5 volumes of lysis buffer containing 30 mM imidazole. Bound tMSP5m,
tMSP5c or tMSP5cm was eluted successively with 5 volumes of 100 mM and then with 5 vol-
umes of 200 mM imidazole lysis buffer. Finally, the buffer was exchanged into 50 mM sodium
phosphate, 200 mM NaCl, pH 7.2 by overnight dialysis at 4˚C. Molar concentration in pure
samples was calculated by absorbance at 280 nm using a molar extinction coefficient (ε280nm)
equal to 8940 M−1cm–1, 10430 M-1cm-1 or 20860 M−1cm–1 for tMSP5m, tMSP5c or tMSP5cm,
respectively.
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Western blot for tMSP5m, tMSP5c and tMSP5cm
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed as
previously described [23]. The proteins were then transferred to nitrocellulose membranes.
Free protein-binding sites were blocked by incubation with TBS/5% nonfat milk for 2 h. The
mAb ANAF16C1-peroxidase conjugate (VMRD Inc., USA) was evaluated at 1/100 dilution
in TBS/0.05% Tween 20/5% nonfat milk. After incubation at 25˚C for 1 h, membranes were
washed five times with TBS/0.05% Tween 20 and the reaction was revealed by adding the col-
orimetric substrate 3,3’-diaminobenzidine tetrahydrochloride (DAB) (Sigma-Aldrich, USA).
ELISA protocols
All field serum samples and controls were assayed in duplicate at room temperature (25˚C).
Commercial competitive ELISA (ccELISA). A ccELISA (VMRD Inc, USA) based on the
fusion protein MBP-MSP5 recommended by the OIE was used in this study, following the
manufacture’s recommendation. Briefly, 70 μl of controls and serum samples were incubated
in the MBP adsorption plate at 25˚C for 30 min. Then, 50 μl of the adsorbed samples were
transferred to the corresponding wells of the Anaplasma Antigen-Coated Plate and incubated
for 1 h. After two washes with wash solution, 50 μl of mAb ANAF16C1-peroxidase conjugate
was added and incubated for 20 min. After washing the plate four times, 50 μl of substrate
solution was added to each well and incubated in darkness for 20 min. Finally, 50 μl of stop
solution was added and detection was performed at 620 nm.
In-house competitive ELISA (hcELISA). Three versions of hcELISA based on tMSP5m
(hcELISA-tMSP5m), tMSP5c (hcELISA-tMSP5c), or tMSP5cm (hcELISA-tMSP5cm) were
evaluated. Polystyrene microplates (Thermo Fisher Scientific Inc, USA) were coated overnight
at 4˚C with 50 μl of purified tMSP5m, tMSP5c, or tMSP5cm (1 μg/well) in PBS. After two
washes with PBS, 300 μl of blocking buffer (PBS/10% fat-free dried milk) was added and the
plates were incubated for 1 h. The plates were washed three times with PBS/0.05% Tween 20
and then incubated with 100 μl of serum samples for 1 h. Thereafter, the same protocol and
reagents of ccELISA were used.
Data analysis
Results were expressed as percent inhibition (%I), which was calculated using the following
formula:
%I ¼ 100 ½1-ðSample OD=Negative Control ODÞ�
The optimal cutoff point, sensitivity and specificity for ccELISA and the three versions of
hcELISA were established by ROC analysis using the MedCalc 8.1.0.0 software. Concordance
between ccELISA and hcELISA-tMSP5m was estimated by Cohen’s kappa value using the
same software [24]. Differences among results obtained with the four cELISA protocols were
evaluated by a Mann Whitney test.
Results
Expression, purification and quality control of recombinant proteins
The comparison of the MSP5 protein sequence of A. marginale and A. centrale (MSP5m and
MSP5c, respectively) revealed 91.5% of identity (Fig 1). The analysis of the primary structure
of MSP5 conducted with TMPred predicted a transmembrane helix in the N-terminus of the
protein (residues 1–25) [21]. The solubility predicted for MSP5 full-length, truncated (residues
28–210) and fusion proteins, overexpressed in E. coli, was 65%, 100% and 100%, respectively
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[22]. MSP5 recombinant proteins (tMSP5m, tMSP5c and tMSP5cm) were expressed with high
efficiency in E. coli, and more than 95% of the recombinant protein was soluble in the bacterial
cytoplasm. The amount of expressed protein was approximately 40 mg, 60 mg and 60 mg per
liter of culture for tMSP5m, tMSP5c and tMSP5cm, respectively. The C-terminal His tag
added to the proteins allowed us to purify large amounts of pure protein (>95%) in a single
step (Fig 2).
The immunoreactivity of tMSP5m, tMSP5c and tMSP5cm was demonstrated by western
blot with the mAb ANAF16C1, which detected the three recombinant proteins. (Fig 3).
Anaplasma infection status based on nPCR results
Anaplasma spp. positive samples were selected and classified using nPCR as gold standard
method. Only 226 DNA samples from 255 cows born and raised in a highly endemic area of
anaplasmosis were nPCR positive for A. marginale and negative for A. centrale. All analyzed
vaccinated cattle (n = 173) were positive for A. centrale and negative for A. marginale, and all
cows born and bred in a farm historically free of anaplasmosis were nPCR negative for both
strains (n = 216).
Antibody detection by ELISA
According to the nPCR results, 226, 173 and 216 serum samples from A. marginale infected,
A. centrale vaccinated and A. marginale/A. centrale negative cattle, respectively, were used for
comparing cELISA tests.
Fig 1. Sequence alignment of A. marginale MSP5 (MSP5m) and A. centrale MSP5 (MSP5c). The transmembrane
regions, excluded from tMSP5m and tMSP5c, are highlighted with horizontal gray bars. Asterisk (�) indicates positions
having a conserved residue; colon (:) indicates conservation among groups of strongly similar characteristics; and
period (.) indicates conservation among groups of weakly similar characteristics.
https://doi.org/10.1371/journal.pone.0211149.g001
Fig 2. SDS-PAGE of fractions from the purification of tMSP5cm, tMSP5c and tMSP5m on a Ni-NTA column.
Lane MW, Molecular weight markers; lanes 1 and 2, post-induction insoluble and soluble fractions of the cell lysate,
respectively; lanes 3 corresponds to the purified protein fraction with 100 mM imidazole. The stain was Coomassie
Brilliant Blue R-250.
https://doi.org/10.1371/journal.pone.0211149.g002
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The frequency distribution of %I for ccELISA and hcELISA-tMSP5m in infected or vacci-
nated and uninfected bovines is shown in Fig 4. Negative and positive sera had a mean %I of
15 and 68 by hcELISA-tMSP5m and 2 and 66 by ccELISA, respectively. The ROC analysis
showed cutoff point values of 30%I with 95.5% of sensitivity and 99.5% of specificity for hcE-
LISA-tMSP5m and 28%I with 95.5% of sensitivity and 96.3% of specificity for ccELISA. The
agreement between ccELISA and hcELISA-tMSP5m results was 97% with a kappa value of
0.94. A total of 29 false positive and 8 false negative results were detected by hcELISA-MSP5m
and/or ccELISA, only 7 of them were coincident by both tests (Table 1).
Fig 3. Western blot of purified tMSP5cm (lane 1), tMSP5c (lane 2) and tMSP5m (lane 3) revealed with the
monoclonal antibody ANAF16C1.
https://doi.org/10.1371/journal.pone.0211149.g003
Fig 4. Frequency distribution of hcELISA-tMSP5m and ccELISA values from uninfected (gray bars); and infected
or vaccinated (black bars) cattle. Cut-off point (dotted line) was 28 and 30%I for ccELISA and hcELISA-tMSP5m,
respectively. Test samples having>28 and>30%I were positive for ccELISA and hcELISA-tMSP5m, respectively.
https://doi.org/10.1371/journal.pone.0211149.g004
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Comparison between ccELISA and hcELISA
The hcELISA based on the truncated MSP5 variants tMSP5m, tMSP5c or tMSP5cm showed
higher sensitivity and specificity than the ccELISA based on MBP-MSP5 antigen. Specificity
was the same for the three versions (99.5%) and sensitivity was 95.5%, 96.2% and 97.2% for
hcELISA-tMSP5m, hcELISA-tMSP5cm and hcELISA-tMSP5c, respectively. The best perfor-
mance was observed with hcELISA-tMSP5c and the highest difference was obtained when
infected and vaccinated cattle were analyzed separately (Table 2). Percent inhibition as mea-
sured by ccELISA and hcELISA in infected and uninfected cattle are shown in Fig 5A; those
levels for cattle infected with A. marginale or vaccinated with A. centrale are shown in Fig 5B.
For the negative population, the median of %I values of hcELISA-tMSP5c and hcELISA-
tMSP5cm were similar and statistically different from the hcELISA-tMSP5m and ccELISA
(p<0.0001). For the positive population, the median of %I values of hcELISA-tMSP5m,
hcELISA-tMSP5cm and ccELISA were similar and statistically different from the hcELISA-
tMSP5c (<0.0001) (Table 3).
Discussion
In this work, truncated MSP5 from A. marginale and A. centrale was expressed without a chap-
erone protein, with high yield, solubility and purity, without losing the immunoreactivity. The
replacement of MBP-MSP5 of A. marginale in the ccELISA with either of the three variants of
the truncated MSP5 of A. marginale (tMSP5m) or A. centrale (tMSP5c) or both together as
fusion protein (tMSP5cm) improved the performance of hcELISA, particularly by increasing
the specificity, which was achieved by eliminating cross-reactions against MBP.
ccELISA is currently used in Argentina to identify cattle herds with enzootic instability for
anaplasmosis, which should be protected by the A. centrale live vaccine, and to assess the
immune response after vaccination [13,25,26]. A. marginale MSP5 has shown distinctive
Table 1. False negative and false positive results by ccELISA (MBP-MSP5) vs hcELISA (tMSP5m) for Anaplasma spp. antibodies detection.
Infected (FN) Uninfected (FP)
Total (n = 399) A. marginale (n = 226) A. centrale (n = 173) n = 216
ccELISA and hcELISA-tMSP5m 7 (1.7%) 4 (1.8%) 3 (1.7) 0 (0.0%)
ccELISA 11 (2.8%) 7 (3.1%) 4 (2.3%) 8 (3.7%)
hcELISA-tMSP5m 11 (2.8%) 2 (0.9%) 9 (5.2%) 1 (0.5%)
Number and proportion of false negative (FN) and false positive (FP) reactions in sera from cattle infected with Anaplasma marginale or vaccinated with A. centrale
(n = 399) and uninfected cattle (n = 216).
https://doi.org/10.1371/journal.pone.0211149.t001
Table 2. Sensitivity and specificity of commercial cELISA (ccELISA) and three versions of in-house cELISA (hcELISA) development for serological diagnosis of cat-
tle infected with Anaplasma marginale or vaccinated with A. centrale.









Specificity (%) 99.5 99.5 99.5 96.3
Sensitivity (%) 95.5 97.2 96.2 95.5
Sensitivity (%) 97.3 95.6 95.6 95.1
Sensitivity (%) 93.1 99.4 97.1 96.0
%I: percent inhibition.
https://doi.org/10.1371/journal.pone.0211149.t002
Fusion MSP5 of A. marginale and centrale improves cELISA
PLOS ONE | https://doi.org/10.1371/journal.pone.0211149 January 23, 2019 8 / 13
attributes to be considered the protein of choice for the diagnosis of anaplasmosis. MSP5 is
encoded by a single copy gene, conserved in A. marginale isolates of different geographical ori-
gins, and shows high identity with MSP5 from other species of Anaplasma [16–18]. Knowles
et al. (1996) developed a cELISA based on the MBP-MSP5 fusion protein and the mAb
ANAF16C1, which was validated using sera from A. marginale naturally or experimentally
infected cattle [14]. This test has also been used to detect antibodies against A. centrale;
Fig 5. Percent inhibition results obtained by hcELISA-tMSP5m (Am), -tMSP5c (Ac), -tMSP5cm (Acm) and
ccELISA (C). A) Anaplasma spp. nPCR negative and positive cattle, and B) A. marginale-infected (left) and A.
centrale-vaccinated (right) cattle. The cut-off values for ccELISA and hcELISA are indicated with a solid and dotted
line, respectively.
https://doi.org/10.1371/journal.pone.0211149.g005
Table 3. Median and interquartile range of percent inhibition (% I) calculated for each of the three versions of hcELISA and ccELISA to detect antibodies in bovines
naturally infected with A. marginale, vaccinated with A. centrale and in non-infected cattle.
hcELISA (%I) ccELISA (%I)
Antigen tMSP5m tMSP5c tMSP5cm MBP-MSP5
Negative cattle (n = 216) 16 (9–22)b 9 (4–17)a 9 (5–17)a 1(-7-9)c
Positive cattle (n = 399) 71 (52–87)a 87 (61–95)b 72 (54–85)a 70 (53–82)a
Infected (n = 226) 77 (62–91)a 82 (52–92)a 75 (56–89)a 74 (56–85)a
Vaccinated (n = 173) 57 (43–77)a 93 (78–97)b 69 (52–81)a 66 (48–79)a
Between brackets: interquartile range. Within the same cattle group, different superscript letters following values indicate statistical significance (p<0.0001).
https://doi.org/10.1371/journal.pone.0211149.t003
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however its actual performance has not been studied in this context. Despite its usefulness, the
test has some disadvantages inherent to the fusion protein that affects specificity [14,19].
Overexpression of the full-length MSP5 protein in E. coli produces insoluble inclusion bod-
ies. High-level expression of many recombinant proteins in E. coli leads to the formation of
highly aggregated proteins commonly referred to as inclusion bodies. The solubility of recom-
binant antigens is a requirement for developing a serological diagnostic test. For this purpose,
the protein aggregates must be solubilized and refolded, with the additional inconvenience
that only a small fraction of the initial protein is recovered [27]. Several reagents (new vectors,
host strains) and strategies (chaperone co-expression, low temperature induction, composition
of the culture media) have been developed to optimize the soluble expression of recombinant
proteins in E. coli [28]. Knowles et al. (1996) avoided precipitation of MSP5 in inclusion bodies
by the co-expression with the MBP chaperone molecule, which boosted solubility and refold-
ing, improving the yield of the soluble recombinant protein [14]. MBP has shown to be more
efficient to solubilize the partner proteins than GST and thioredoxin (Trx), two other com-
monly used chaperon proteins [29]. However, MBP is involved in the maltose/maltodextrin
system of E. coli and interferes with the diagnosis test [19]. This ubiquitous bacterium is often
the cause of enteric and mammary infections in bovines, and prompts antibodies against
MBP. Therefore, the sera analyzed by cELISA based on MBP-MSP5 require previous adsorp-
tion with MBP to avoid false positive reactions [14]. The sensitivity and specificity reported for
ccELISA in A. marginale naturally infected cattle varied according to the gold standard used
for bovine classification, with sensitivity ranging from 65.2% to 99.2% and specificity from
83.3% to 99.5% [10,15,30].
The in silico analysis showed that the most favorable condition to express the soluble
recombinant MSP5 protein was without its transmembrane region. Cloning and expression
of recombinant proteins without the transmembrane region may drastically increase the
expression levels and solubility of heterologous proteins expressed in E. coli [31]. Replacing
MBP-MSP5 fusion protein in ccELISA with truncated MSP5 proteins (tMSP5m, tMSP5c or
tMSP5cm) reduced the running time and increased the test sensitivity and specificity for
detecting antibodies against both A. marginale and A. centrale. The novel antigens fulfilled the
requirements for determining the epidemiological status of Anaplasma spp. in the endemic
area where discrimination between these species is not required.
In this work, the expression of the truncated MSP5 without N-terminus transmembrane
helix (residues 1–27) of A. marginale (tMSP5m), A. centrale (tMSP5c) or fusion protein
(tMSP5cm) was obtained in the soluble fraction with high purity in a single step and did
not form aggregates during its conservation. Chung et al. (2014) expressed GST-MSP5 in
E. coli by solubilizing the transmembrane helix in detergent micelles and the crude soluble
fraction was used in a ccELISA for detecting antibodies against A. marginale. Replacement
of MBP-MSP5 with GST-MSP5 showed higher specificity, comparable sensitivity and
improved resolution of the ccELISA [19]. However, yield, stability and facility of production
for the fusion protein were not reported; the efficacy of this test to identify cattle vaccinated
with A. centrale was not reported either. The ccELISA was developed in the United States,
where A. centrale is not present. In Argentina, as well as in other countries, the vaccine strain
of A. centrale is used in cohorts of calves up to 10 months old in areas with enzootic instabil-
ity and in calves from the anaplasmosis-free zones which will be moved to an endemic region
[32–34].
A cELISA based on crude A. centrale antigen was able to discriminate A. marginale in natu-
rally infected cattle from A. centrale in vaccinated cattle with 97.3% or 98.6% of sensitivity for
beef and dairy cattle, respectively, and 98.8% of specificity for both. However, crude antigens
are difficult to standardize and there is no commercial test available for that purpose [35].
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The novel antigens, which lack a chaperone protein, have allowed us to simplify the ccE-
LISA (MBP-MSP5 antigen) protocol, avoiding the sera adsorption step used to eliminate most
of false positive reactions. The three versions of hcELISA showed better performance than ccE-
LISA in cattle infected with A. marginale as well as in those immunized with A. centrale. The
high specificity (99.5%) observed for hcELISA-tMSP5m, -tMSP5c and tMSP5mc, revealed the
elimination of cross-reactions detected by ccELISA, even after serum adsorption with MBP.
The hcELISA showed identical (hcELISA-tMSP5m) or higher (hcELISA-tMSP5c and–
tMSP5cm) sensitivity than that detected by ccELISA. Interestingly, the highest sensitivity was
detected by hcELISA-MSP5c, followed by hcELISA-tMSP5cm, both including MSP5 of A. cen-
trale. When sera from infected and vaccinated cattle were evaluated separately, the sensitivity
and the median values of %I (hcELISAs) were enhanced when homologous antigens were
used. The use of the fusion protein (tMSP5cm) increased the overall sensitivity by improving
the detection level in the vaccinated group.
In conclusion, the truncated MSP5 protein allowed an increase in the specificity of the
cELISA to 99.5% and the generation of a fusion protein among A. centrale and A. marginale
tMSP5 protein allowed an increase in the cELISA sensitivity when vaccinated animals were
analyzed.
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